1-(3,5-Dimethylpyridin-2-yl)piperazine → HCID 71251952, compound
Reaction equation
[O:1]=[C:2]1[NH:7][CH2:6][CH2:5][CH2:4][N:3]1[C:8]1[CH:18]=[CH:17][C:11]([C:12]([O:14]CC)=O)=[CH:10][CH:9]=1.[CH3:19][C:20]1[C:21]([N:27]2[CH2:32][CH2:31][NH:30][CH2:29][CH2:28]2)=[N:22][CH:23]=[C:24]([CH3:26])[CH:25]=1>>[CH3:19][C:20]1[C:21]([N:27]2[CH2:28][CH2:29][N:30]([C:12]([C:11]3[CH:10]=[CH:9][C:8]([N:3]4[CH2:4][CH2:5][CH2:6][NH:7][C:2]4=[O:1])=[CH:18][CH:17]=3)=[O:14])[CH2:31][CH2:32]2)=[N:22][CH:23]=[C:24]([CH3:26])[CH:25]=1Participants
3
Procedure
Using ethyl 4-(2-oxotetrahydropyrimidin-1-yl)benzoate (84 mg) described in Preparation Example 60 and 1-(3,5-dimethylpyridin-2-yl)piperazine (65 mg) described in Preparation Example 79 and by the reaction and treatment in the same manner as in Example 109, the title compound (103 mg) was obtained.
Workup
- customdescribed in Preparation Example 79 and by the reaction and treatment in the same manner as in Example 109
Sources & evidence
- ORD record
- ord-9e4ee17e5c814364b7b73e44a55329a6
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…